Skip to main content

Table 2 Toxicity documentation: measurement points t1-t8 (Percentages)

From: Is standard breast-conserving therapy (BCT) in elderly breast cancer patients justified? A prospective measurement of acute toxicity according CTC-classification

Scale

Mesurement-point

Grade 0

Grade 1

Grade 2

Grade 3

Grade 4

Skin: Dermatitis

t1

91.01%

6.74%

1.12%

1.12%

0.00%

 

t2

86.96%

11.96%

1.09%

0.00%

0.00%

 

t3

75.00%

22.83%

2.17%

0.00%

0.00%

 

t4

58.06%

37.63%

3.23%

1.08%

0.00%

 

t5

33.70%

47.83%

17.39%

1.09%

0.00%

 

t6

28.57%

51.65%

19.78%

0.00%

0.00%

 

t8

80.00%

17.14%

2.86%

0.00%

0.00%

Skin: Pigmentation

t1

100.00%

0.00%

0.00%

0.00%

0.00%

 

t2

100.00%

0.00%

0.00%

0.00%

0.00%

 

t3

96.74%

3.26%

0.00%

0.00%

0.00%

 

t4

95.70%

4.30%

0.00%

0.00%

0.00%

 

t5

89.13%

10.87%

0.00%

0.00%

0.00%

 

t6

67.03%

31.87%

1.10%

0.00%

0.00%

 

t8

80.00%

20.00%

0.00%

0.00%

0.00%

Breast: Symmetry

t1

34.44%

40.00%

22.22%

3.33%

0.00%

 

t2

33.70%

40.22%

22.83%

3.26%

0.00%

 

t3

33.70%

40.22%

22.83%

3.26%

0.00%

 

t4

33.33%

40.86%

22.58%

3.23%

0.00%

 

t5

32.61%

41.30%

22.83%

3.26%

0.00%

 

t6

31.87%

42.86%

23.08%

2.20%

0.00%

 

t8

25.71%

45.71%

25.71%

2.87%

0.00%

Breast: Lymphedema

t1

28.89%

66.67%

4.44%

0.00%

0.00%

 

t2

32.61%

64.13%

3.26%

0.00%

0.00%

 

t3

29.35%

66.30%

3.26%

1.09%

0.00%

 

t4

22.58%

73.12%

4.30%

0.00%

0.00%

 

t5

21.74%

73.91%

4.35%

0.00%

0.00%

 

t6

20.88%

74.73%

4.40%

0.00%

0.00%

 

t8

25.71%

71.43%

2.86%

0.00%

0.00%

Breast: Pain

t1

84.44%

12.22%

3.33%

0.00%

0.00%

 

t2

84.78%

14.13%

1.09%

0.00%

0.00%

 

t3

84.78%

11.96%

3.26%

0.00%

0.00%

 

t4

83.87%

13.98%

2.15%

0.00%

0.00%

 

t5

76.09%

21.74%

2.17%

0.00%

0.00%

 

t6

79.12%

17.58%

3.30%

0.00%

0.00%

 

t8

91.43%

8.57%

0.00%

0.00%

0.00%